Literature DB >> 8004097

An explanation for the constitutive exon 9 cassette splicing of the DMD gene.

J Reiss1, F Rininsland.   

Abstract

Approximately half of the transcripts of the DMD gene isolated from peripheral blood lymphocytes and detected by RT-PCR do not contain exon 9. This 'exon skipping' can be observed to a variable extent in all tissues not specifically expressing the gene product 'dystrophin'. The shorter transcript is rare in muscle, heart and brain. Similar results were found in mice. Since the 3' end of exon 9 reflects the consensus sequence of a 3' splice site, it is suggested that exon 9 due to this sequence element is 'recognized' as an intron and removed from an RNA intermediate. This model is supported by a mathematical comparison of real and putative splice sites within the gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004097     DOI: 10.1093/hmg/3.2.295

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping.

Authors:  Lawrence T Bish; Meg M Sleeper; Sean C Forbes; Bingjing Wang; Caryn Reynolds; Gretchen E Singletary; Dennis Trafny; Kevin J Morine; Julio Sanmiguel; Sylvain Cecchini; Tamas Virag; Adeline Vulin; Cyriaque Beley; Janet Bogan; James M Wilson; Krista Vandenborne; Joe N Kornegay; Glenn A Walter; Robert M Kotin; Luis Garcia; H Lee Sweeney
Journal:  Mol Ther       Date:  2011-12-06       Impact factor: 11.454

2.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

3.  Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs.

Authors:  Toshifumi Yokota; Qi-Long Lu; Terence Partridge; Masanori Kobayashi; Akinori Nakamura; Shińichi Takeda; Eric Hoffman
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

4.  Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Hiroyuki Awano; Emma Tabe Eko Niba; Masafumi Matsuo
Journal:  Hum Genet       Date:  2015-07-08       Impact factor: 4.132

5.  A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.

Authors:  Van Khanh Tran; Zhujun Zhang; Mariko Yagi; Atsushi Nishiyama; Yasuaki Habara; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2005-08-30       Impact factor: 3.172

Review 6.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

7.  Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient.

Authors:  Takashi Saito; Akinori Nakamura; Yoshitsugu Aoki; Toshifumi Yokota; Takashi Okada; Makiko Osawa; Shin'ichi Takeda
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

8.  Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.

Authors:  Toshifumi Yokota; Akinori Nakamura; Tetsuya Nagata; Takashi Saito; Masanori Kobayashi; Yoshitsugu Aoki; Yusuke Echigoya; Terence Partridge; Eric P Hoffman; Shin'ichi Takeda
Journal:  Nucleic Acid Ther       Date:  2012-08-13       Impact factor: 5.486

9.  Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.

Authors:  Caroline Le Guiner; Marie Montus; Laurent Servais; Yan Cherel; Virginie Francois; Jean-Laurent Thibaud; Claire Wary; Béatrice Matot; Thibaut Larcher; Lydie Guigand; Maeva Dutilleul; Claire Domenger; Marine Allais; Maud Beuvin; Amélie Moraux; Johanne Le Duff; Marie Devaux; Nicolas Jaulin; Mickaël Guilbaud; Virginie Latournerie; Philippe Veron; Sylvie Boutin; Christian Leborgne; Diana Desgue; Jack-Yves Deschamps; Sophie Moullec; Yves Fromes; Adeline Vulin; Richard H Smith; Nicolas Laroudie; Frédéric Barnay-Toutain; Christel Rivière; Stéphanie Bucher; Thanh-Hoa Le; Nicolas Delaunay; Mehdi Gasmi; Robert M Kotin; Gisèle Bonne; Oumeya Adjali; Carole Masurier; Jean-Yves Hogrel; Pierre Carlier; Philippe Moullier; Thomas Voit
Journal:  Mol Ther       Date:  2014-08-04       Impact factor: 11.454

10.  Skipping of multiple CFTR exons is not a result of single exon omissions.

Authors:  A Rickers; F Rininsland; L Osborne; J Reiss
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.